Acadia Pharmaceuticals Inc

ACAD 
(NASDAQ) 
 
$ 13.03
Updated 00:51:49
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 784,036
High $ 13.30
Low $ 12.87
Open $ 13.30
ISIN
Prev close $ 13.30
# of shares 125.01M
Market cap 1,628.84M USD
Intraday

Market closed
Acadia Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  13.03 -12.7% Stock price decreasing -25.9% Stock price decreasing -27.6% Stock price decreasing -57.9% Stock price decreasing -58.1% Stock price decreasing
Powered by TradingView

News about Acadia Pharmaceuticals Inc

  • English
  • Regulatory news
13:00
 
17 Aug
 
17 Aug
 
16 Aug
 
15 Aug
 
14 Aug
 
13 Aug
 
13 Aug
 
12 Aug
 
11 Aug
 

Company profile

Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
18 August 2018 20:49:57
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180816.1 - EUROWEB1 - 2018-08-18 21:49:57 - 2018-08-18 20:49:57 - 1000 - Website: OKAY